Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2006-10-24
2010-02-09
Spector, Lorraine (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S141100, C424S145100, C424S135100, C424S133100, C530S387900, C530S388100, C530S388230
Reexamination Certificate
active
07658920
ABSTRACT:
Polypeptide growth factor ZVEGF3, methods of making it, polynucleotides encoding it, antibodies that bind to it, and methods of using them are disclosed. The polypeptide comprises an amino acid segment that is at least 90% identical to residues 46-163 of SEQ ID NO:2 or residues 235-345 of SEQ ID NO:2. Multimers of the polypeptide are also disclosed. The polypeptide, multimeric proteins, and polynucleotides can be used in the study and regulation of cell and tissue development, as components of cell culture media, and as diagnostic agents. The antibodies may be used to inhibit cell growth.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5910573 (1999-06-01), Pluckthun et al.
patent: 6391311 (2002-05-01), Ferrara et al.
patent: 6814965 (2004-11-01), Gao et al.
patent: 7335357 (2008-02-01), Klagsbrun et al.
patent: 95/14772 (1995-06-01), None
patent: 99/37671 (1999-07-01), None
patent: 99/47677 (1999-09-01), None
patent: 00/04183 (2000-01-01), None
patent: 00/18212 (2000-04-01), None
patent: 00/24774 (2000-05-01), None
patent: 00/32221 (2000-06-01), None
patent: 00/37641 (2000-06-01), None
patent: 00/39284 (2000-07-01), None
patent: 00/53753 (2000-09-01), None
patent: 00/53756 (2000-09-01), None
patent: 00/53758 (2000-09-01), None
patent: 00/53760 (2000-09-01), None
patent: 00/59940 (2000-10-01), None
patent: 00/70050 (2000-11-01), None
The Institute for Genomic Research, EST 40974, Jul. 3, 1997.
The Institute for Genomic Research, EST W21436, Jul. 3, 1997.
Hillier et al., EST 528192, May 9, 1996.
Adams et al., EST 977627, Apr. 21, 1997.
Marra et al., EST 1759738, Jun. 16, 1998.
Marra et al., EST 2236990, Feb. 10, 1999.
National Cancer Institute, Cancer Genome Anatomy Project, EST 2290164, Mar. 3, 1999.
Marra et al., EST 2425258, Apr. 15, 1999.
Ottenwaelder et al., EST 2476351, Apr. 30, 1999.
Duesterhoeft et al., EST 2888195, Jul. 7, 1999.
Ottenwaelder et al., EST 2890217, Jul. 8, 1999.
National Cancer Institute, Cancer Genome Anatomy Project, EST 3182898, Sep. 20, 1999.
Marra et al., EST 3555592, Dec. 3, 1999.
Tsai et al., GenBank Accession No. AF091434, Oct. 1, 1999.
Marra et al., The WashU-HHMI Mouse EST Project, EST 744345, Sep. 23, 1996.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC1302516, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC1303909, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2453444, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2451669, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3440025, Jul. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2547850, Feb. 4, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2962366, Sep. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3598059, Sep. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3073703, Mar. 12, 1998.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC4825396, Jul. 9, 1998.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC5832763, Feb. 20, 1999.
Li et al., “PDGF-C is a new protease-activated ligand for the PDGF α-receptor,”Nature Cell Biol.2:302-309, 2000.
Gao Zeren
Hart Charles E.
Piddington Christopher S.
Sheppard Paul O.
Shoemaker Kimberly E.
Bastian Kevin L.
Parker Gary E.
Sherbina Nicholas V.
Spector Lorraine
ZymoGenetics Inc.
LandOfFree
Method of inhibiting the activity of growth factor homolog... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting the activity of growth factor homolog..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the activity of growth factor homolog... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196916